Home
About Us
Product Pipeline
Doctors & Researchers
Patients
News
Contact Us
Developing Novel Therapies to Enhance Patients' Lives
Tolera Therapeutics is developing novel therapies and technologies, to offer patients and their doctors, targeted and safer solutions, for immune modulation and related medical needs.
Markets
Developing more targeted and safer immune response therapies.
Organ transplant
Immune modulation
Oncology
Product Pipeline
Anti-rejection therapy
Induction therapy
Immune modulation
Oncology
Tolera News
Breaking News-
Tolera Chief Medical Officer Maria Siemionow performs first US face transplant
Tolera Wins $2 Million in 21st Century Jobs Business Plan Competition
Tolera Raises $8 Million
Tolera adds new Board Members
Parfet named to Tolera Board
Related Articles
Tolera Fact Sheet
© 2008 Tolera Therapeutics, Inc. 4717 Campus Drive, Kalamazoo, MI 49008